Bioavailability Enhancement Webinar Series - Amorphous Solid Dispersion Formulations Using The Spray Dry Process

Amorphous solid dispersion technology has been developed to be a preferred formulation option with a wide range of applicability for improving solubility and dissolution rate of insoluble compounds. When amorphous compounds are delivered orally, their solubility advantage can translate into significantly enhanced bioavailability. This webinar will discuss the application of amorphous solid dispersions via the spray drying process in preclinical formulation identification, including stability and performance considerations. Illustrative case studies will be presented.